These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12486376)
1. [Contribution of DNA chips in lung cancer: an update]. Gazaille V; Bernaudin JF Rev Pneumol Clin; 2002 Nov; 58(5 Pt 1):268-76. PubMed ID: 12486376 [TBL] [Abstract][Full Text] [Related]
2. [Non small cell lung cancer gene expression profiles by cDNA microarrays]. Ouyang QC; Hu CP; Shi LJ Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):9-12. PubMed ID: 12934383 [TBL] [Abstract][Full Text] [Related]
3. [Molecular biology in the diagnosis of lung cancer]. Haugen A Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3283-5. PubMed ID: 16327855 [TBL] [Abstract][Full Text] [Related]
4. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of the gene expression in non-small cell lung cancer by cDNA array]. Takada M Hokkaido Igaku Zasshi; 2004 Jul; 79(4):427-37. PubMed ID: 15373214 [No Abstract] [Full Text] [Related]
6. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer. Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064 [TBL] [Abstract][Full Text] [Related]
7. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482 [TBL] [Abstract][Full Text] [Related]
8. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569 [TBL] [Abstract][Full Text] [Related]
9. A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202 [TBL] [Abstract][Full Text] [Related]
10. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Yamagata N; Shyr Y; Yanagisawa K; Edgerton M; Dang TP; Gonzalez A; Nadaf S; Larsen P; Roberts JR; Nesbitt JC; Jensen R; Levy S; Moore JH; Minna JD; Carbone DP Clin Cancer Res; 2003 Oct; 9(13):4695-704. PubMed ID: 14581339 [TBL] [Abstract][Full Text] [Related]
11. [DNA chip analysis of gene expression patterns in poorly-differentiated human stage I lung adenocarcinoma]. Xing GH; Zhang JC Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):36-9. PubMed ID: 15059353 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703 [TBL] [Abstract][Full Text] [Related]
13. Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray. Kikuchi T; Daigo Y; Ishikawa N; Katagiri T; Tsunoda T; Yoshida S; Nakamura Y Int J Oncol; 2006 Apr; 28(4):799-805. PubMed ID: 16525627 [TBL] [Abstract][Full Text] [Related]
14. The future of clinical cancer management: one tumor, one chip. Yeatman TJ Am Surg; 2003 Jan; 69(1):41-4. PubMed ID: 12575779 [TBL] [Abstract][Full Text] [Related]
15. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Zhong S; Fields CR; Su N; Pan YX; Robertson KD Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644 [TBL] [Abstract][Full Text] [Related]
17. DualChip microarray as a new tool in cancer research. Gillet JP; de Longueville F; Remacle J Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734 [TBL] [Abstract][Full Text] [Related]
18. [Gene expression of MMP1 and TIMP1 in lung cancer detected with a cDNA microarray technique]. Ouyang QC; Hu CP; Liang QH Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):227-8. PubMed ID: 14653073 [TBL] [Abstract][Full Text] [Related]